Match Document Document Title
US20140199350 CHIMERIC TOPICAL VACCINE FOR HAEMOPHILUS INFLUENZAE-INDUCED DISEASE  
Provided are delivery systems for topically administering a chimeric protein including the NTHi twitching pilus major subunit protein (PilA) presenting a portion of the NTHi OMP P5 protein. Also...
US20120276154 CREATION OF HAIR FOLLICLES IN TISSUE-ENGINEERED SKIN GRAFTS  
A living tissue-engineered skin graft having a potential to develop hair follicles includes a multilayered skin-like structure of alternating nanofiber mats and layers of fibroblasts assembled in...
US20110182995 MEDICAL AND DENTAL BIOMATERIAL AND METHOD OF USE FOR THE SAME  
The embodiments herein provide a dental and medical biomaterial and its use for sealing and/or filling the tooth and bone cavities. In the embodiments herein, the calcium salt, calcium oxide,...
US20110159051 Composite for Thermo-Sensitive Cell-Tissue Transplanted Scaffold and Use thereof  
A composite comprising a stem cell; a biodegradable layer, which can provide an environment for the stem cell to grow and to differentiate, and; a N-isopropylacrylamide (NIPAAm), which can...
US20110206765 Non-Typeable Haemophilus Influenzae Vaccines and Their Uses  
Provided are non-typeable Haemophilus influenzae vaccines useful for the treatment of chronic obstructive pulmonary disease and asthma in a patient. In certain aspects, the vaccine is a...
US20130202655 Vaccines, Methods of Administering Vaccines, Methods and Products for Treating and/or Delaying Onset of Dysplastic Lesions, and Wafers for Oral Administration  
Methods and products for treating and/or delaying onset of dysplastic lesions, and wafers for oral administration employ dry powder compositions including myo-inositol. Methods for administering a...
US20130149353 Solid Dosage Form That Promotes Reliable Oral, Esophageal and GI Transit  
A solid dosage form designed to facilitate rapid and reliable oral, esophageal and GI transit has a surface area of the contact patch, i.e., the area of contact between the dosage form and the...
US20120141545 Solid Dosage Form That Promotes Reliable Oral, Esophageal and GI Transit  
A solid dosage form designed to facilitate rapid and reliable oral, esophageal and GI transit has a surface area of the contact patch, i.e., the area of contact between the dosage form and the...
US20120141544 Solid Dosage Form That Promotes Reliable Oral, Esophageal and GI Transit  
A solid dosage form designed to facilitate rapid and reliable oral, esophageal and GI transit has a surface area of the contact patch, i.e., the area of contact between the dosage form and the...
US20120321673 TRANSDERMAL DRUG DELIVERY SYSTEM AND METHOD OF USING THE SAME  
A transdermal drug delivery system comprising a steroid as an active agent, wherein the steroid may be clobetasol propionate, betamethasone dipropionate, amcinonide, or loteprednol etabonate. The...
US20120231050 Synthetic Lactone Formulations and Method of Use  
Natural and synthetic compounds having a lactone structure methods for alleviation of pain, especially pain associated with disorders such as melanoma, leukemia, breast cancer, lung cancer,...
US20130110066 Foam and Delivery System for Treatment of Postpartum Hemorrhage  
Medical implants and methods useful in treating postpartum hemorrhage are disclosed. The implants, in some embodiments, comprise polyurethane foams having advantageous mechanical and other...
US20120093892 MINOCYCLINE ORAL DOSAGE FORMS FOR THE TREATMENT OF ACNE  
Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne.
US20100330131 MINOCYCLINE ORAL DOSAGE FORMS FOR THE TREATMENT OF ACNE  
Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne.
US20120171260 Stent And Delivery System With Reduced Chemical Degradation  
Stents and delivery systems with reduced chemical degradation and methods of sterilizing the same are disclosed.
US20120058153 SYNTHETIC NANOCARRIER VACCINES COMPRISING PROTEINS OBTAINED OR DERIVED FROM HUMAN INFLUENZA A VIRUS HEMAGGLUTININ  
This invention relates to compositions and methods that can be used immunize a subject against influenza. Generally, the compositions and methods include polypeptides obtained or derived from...
US20110150986 QUININE FORMULATIONS, METHOD OF MAKING, AND METHO OF USE THEREOF  
Disclosed herein are quinine formulations and methods of using quinine formulations. Specifically disclosed herein are solid oral dosage forms which can be administered as a capsule or tablet, or...
US20120087952 Pulmonary Delivery in Treating Disorders of the Central Nervous System  
A method for treating a disorder of the central nervous system includes administering to the respiratory tract of a patient a drug which is delivered to the pulmonary system, for instance to the...
US20110054237 Methods and Systems for Magnetic Focusing of Therapeutic, Diagnostic or Prophylactic Agents to Deep Targets  
Systems and methods are disclosed for trapping or focusing magnetizable particles comprising therapeutic agents at a distance using a dynamic magnetic field and feedback control, to enable the...
US20130078299 Transdermal Patches Having Ionized Beam Crosslinked Polymers and Improved Release Characteristics  
Crosslinked hydrogel-based transdermal pharmaceutical formulations. The hydrogel transdermal formulations. Transdermal patches are useful for administering a variety of drugs to patients. The...
US20140056949 Controlled Release Mucoadhesive Systems  
Formulations for chemoprevention of oral cancer and precancerous lesions, and for methods for preparing the formulations are described.
US20120093880 METHOD AND KIT FOR TOPICAL ELIMINATION OF PSORIATIC LESIONS WITH A CAUSTIC APPLICATOR  
A method and kit for eliminating a psoriatic lesion involves removal of loose psoriatic scales if present, and moistening remaining scales to a depth to or just above epidermal tissue underlying...
US20120282300 PROTEIN BIOMATERIALS AND BIOCOACERVATES AND METHODS OF MAKING AND USING THEREOF  
The present invention relates to protein biocoacervates and biomaterials and the methods of making and using protein biocoacervates and biomaterials. More specifically the present invention...
US20110212157 DERMAL DELIVERY  
The present invention describes systems and methods for treating disorders and/or conditions associated with the dermal level of the skin. Such disorders include acne, hyperhidrosis, bromhidrosis,...
US20150010641 MICRO-, SUBMICRO- AND NANO-STRUCTURES CONTAINING AMARANTH PROTEIN  
The invention relates to micro-, submicro- or nano-structures comprising amaranth protein, optionally combined with at least one other biopolymer, which structures are suitable for use as an...
US20130004547 ORAL VACCINES PRODUCED AND ADMINISTERED USING EDIBLE MICRO-ORGANISMS INCLUDING LACTIC ACID BACTERIAL STRAINS  
The invention provides for anti-pathogen vaccines produced in recombinant bacteria and/or transgenic plants and administered through standard vaccine introduction methods or oral administration....
US20120201857 Transdermal delivery system for therapeutics  
The present invention provides a method and product for transdermal delivery of therapeutics, including neurotoxins and methods for use thereof. The method and system comprises pharmaceutical...
US20150252081 METHODS AND COMPOSITIONS FOR CONTROLLING ASSEMBLY OF VIRAL PROTEINS  
Provided herein are methods and compositions for controlling assembly of modified viral core proteins, for example, into a viral capsid or a nanocage. In some embodiments, the disclosed modified...
US20130156818 METHODS AND COMPOSITIONS FOR CONTROLLING ASSEMBLY OF VIRAL PROTEINS  
Provided herein are methods and compositions for controlling assembly of modified viral core proteins, for example, into a viral capsid or a nanocage. In some embodiments, the disclosed modified...
US20130236517 Apatite Forming Biomaterial  
The present invention relates to chemically bonded ceramic biomaterials, especially a dental material or an implant material. The main binder system forms a chemically bonded ceramic upon...
US20120082721 Enteric coating  
The present invention refers to a dosage form comprising an enteric coating in a specific amount, and to the use of enteric coating compositions for preparing a dosage form. Furthermore, the...
US20120045479 Dry Powder Formulations, Vaccines and Methods  
Respirable dry powder formulations comprise myo-inositol and leucine. Dry powder human papillomavirus (HPV) vaccine formulations comprise a least one HPV capsid protein and a carrier comprising...
US20140134213 TREATMENT OF MICROBIAL INFECTIONS  
The present application relates to an anti-microbial system for use in the treatment of microbial infections or control of microbial contamination, which avoids the use of antibiotics. Such...
US20130142835 SYNTHETIC SCAFFOLDS AND ORGAN AND TISSUE TRANSPLANTATION  
Articles, compositions, and methods for growing tissues and organs using bioreactors, including rotating bioreactors, are provided. Synthetic scaffolds for growing artificial tissue and organ...
US20110293676 Oral Cephalotaxine Dosage Forms  
The present disclosure provides oral dosage forms comprising a cephalotaxine and a pharmaceutically acceptable carrier selected from protein, carbohydrate and lipid, an oral dosage form comprising...
US20150110839 HIGH-LOADING, CONTROLLED-RELEASE MAGNESIUM ORAL DOSAGE FORMS AND METHODS FOR MAKING AND USING SAME  
Disclosed are high loading, controlled-release dosage forms for oral administration of magnesium salts. For example, an oral dosage form can comprise from about 80% to about 95% magnesium lactate...
US20130224264 HIGH-LOADING, CONTROLLED-RELEASE MAGNESIUM ORAL DOSAGE FORMS AND METHODS FOR MAKING AND USING SAME  
Disclosed are high loading, controlled-release dosage forms for oral administration of magnesium salts. For example, an oral dosage form can comprise from about 80% to about 95% magnesium lactate...
US20130115286 ORAL ADMINISTRATION FORMS FOR CONTROLLED RELEASE OF RIFAMPICIN FOR THE TREATMENT OF BACTERIAL INFECTIONS AND INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT  
Oral administration forms are described for the controlled release of an antibiotic selected from the group consisting of rifampicin, rifabutin, rifapentine, rifalazil and mixtures thereof, for...
US20130095177 METHOD OF PREPARING AN ORAL DOSAGE FORM COMPRISING FINGOLIMOD  
The present invention relates to a method of preparing an intermediate containing fingolimod, a method of preparing granules containing fingolimod, a method of preparing an oral dosage form...
US20110014247 METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS  
This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral...
US20110150945 ORAL PHARMACEUTICAL FORMULATION FOR OMEPRAZOLE COMPRISING A SPECIFIC SEPARATION LAYER  
The invention relates to an enteric coated oral pharmaceutical formulation comprising, as the active ingredient, omeprazole, an alkaline salt of omeprazole, an enantiomer of omeprazole, or an...
US20130202656 SYSTEMS AND KITS FOR THE FABRICATION OF TISSUE PATCHES  
Tissue patches and associated systems and methods are described. Certain embodiments are related to inventive systems and methods in which tissue patches can be made quickly and robustly without...
US20120141552 ULTRASOUND TECHNOLOGY TO CONTROL THE SPATIAL ORGANIZATION OF CELLS AND PROTEINS IN ENGINEERED TISSUES  
The present invention is directed to methods of inducing spatial organization of cells an in vitro culture system using ultrasound technology. The invention is further directed to methods of...
US20120276167 IMMUNOPROTECTION BY ORAL ADMINISTRATION OF RECOMBINANT LACTOCOCCUS LACTIS MINI-CAPSULES  
In one embodiment, the present invention provides for an edible mini-capsule form of live, non-persisting, recombinant Lactococcus lactis (L. lactis) vaccine against a pathogen such as the highly...
US20110020450 TITRATABLE DOSAGE TRANSDERMAL DELIVERY SYSTEM  
The present invention relates to a titratable dosage transdermal delivery system for systemic delivery of a therapeutic agent or drug. The system comprises a plurality of patch units that are...
US20130224268 TOPICAL DELIVERY OF HORMONAL AND NON HORMONAL NANO FORMULATIONS, METHODS OF MAKING AND USING THE SAME  
The present invention relates to methods for treating, preventing, minimizing, and/or diminishing signs of aging in the skin comprising topically administering to the subject in need thereof a...
US20120021051 ZALEPLON GASTRORETENTIVE DRUG DELIVERY SYSTEM  
A biodegradable, multi-layered controlled release gastroretentive dosage form which is optionally divided into a first dosage of zaleplon for controlled release and a second dosage of zaleplon for...
US20120201866 CISTUS EXTRACTS  
The present invention relates to the use of a nasal spray made from Cistus extracts for the prevention and/or treatment of viral and/or bacterial diseases of the oral and pharyngeal cavities.
US20130052256 NAIL DISCOLORATION AND FUNGUS TREATMENT  
A system and method for treating human nails afflicted with fungus is now disclosed. The system comprises a hydrogel dressing or pad, a topical agent consisting of a nanosilver treatment agent, a...
US20120015003 Layered Scaffold Suitable for Osteochondral Repair  
The invention relates to a method for producing a multi-layer collagen scaffold. The method generally comprises the steps of: preparing a first suspension of collagen and freezing or lyophilising...